Distinguishing premature ejaculation from other sexual function disorders

Postgraduate Medicine

Volumn 120, Issue 1, 2008, Pages 54-63

  Miner, Martin ^a,c   Hellstrom, Wayne J G ^b  

^a BROWN UNIVERSITY   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; DAPOXETINE; EMLA; FLUOXETINE; FLUVOXAMINE; PAROXETINE; PROSTAGLANDIN E1; SERTRALINE; SILDENAFIL; TADALAFIL; TRAMADOL; VARDENAFIL;

ANAMNESIS; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; DEVICE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; DRUG DOSE TITRATION; ERECTILE DYSFUNCTION; HUMAN; MALE SEXUAL DYSFUNCTION; PENIS PROSTHESIS; PERSONALITY DISORDER; PREMATURE EJACULATION; PREVALENCE; PRIMARY MEDICAL CARE; RISK FACTOR; SEX THERAPY; SEXUAL DYSFUNCTION; SEXUAL HEALTH; VACUUM CONSTRICTION DEVICE; EJACULATION; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

DIAGNOSIS, DIFFERENTIAL; EJACULATION; ERECTILE DYSFUNCTION; HUMANS; MALE; MEDICAL HISTORY TAKING; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 45549092420     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2008.04.1761     Document Type: Article

References (75)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. Moreira ED Jr. Help-seeking behaviour for sexual problems: the Global Study of Sexual Attitudes and Behaviors. Int J Clin Pract. 2005;59(1):6-16.
3. Shabsigh R, Perelman MA. Differences in perception of the impact of and treatment options for premature ejaculation among men and physicians. J Sex Med. 2006;3(suppl 1):58.
4. Lawrence S. When patients won't speak up. Medical Economics. 2005;82(16):29, 31.
5. Masters W, Johnson V. Human Sexual Inadequacy. Boston, MA: Little Brown and Co; 1970.
6. Halvorsen JG, Metz ME. Sexual dysfunction, Part I: Classification, etiology, and pathogenesis. J Am Board Fam Pract. 1992;5(1):51-61.
7. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007;51(3):816-824.
8. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537-544.
9. Lewis RW, Fugl-Meyer KS, Bosch R, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med. 2004;1(1):35-39
10. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61.
11. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822-830.
12. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-326.
13. Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291(24):2978-2984.
14. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004;20(5):607-617.
15. Esposito K, Giugliano F, Martedi E, et al. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care. 2005;28(5):1201-1203.
16. Nandipati KC, Raina R, Agarwal A, Zippe CD. Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management. Drugs Aging. 2006;23(2):101-117.
17. Cheitlin MD. Erectile dysfunction: the earliest sign of generalized vascular disease? J Am Coll Cardiol. 2004;43(2):185-186.
18. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003;89(3):251-253.
19. Billups KL. Erectile dysfunction as a marker for vascular disease. Curr Urol Rep. 2005;6(6):439-444.
20. Kirby M, Jackson G, Simonsen U. Endothelial dysfunction links erectile dysfunction to heart disease. Int J Clin Pract. 2005;59(2):225-229.
21. Jackson G. The importance of risk factor reduction in erectile dysfunction. Curr Urol Rep. 2007;8(6):463-466.
22. American Urological Association. Management of erectile dysfunction: American Urological Association (AUA) Education and Research, Inc. http://www.auanet.org/. Accessed March 13, 2008.
23. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol. 1996;78(2):257-261.
24. Donatucci C, Eardley I, Buvat J, et al. Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification. J Sex Med. 2004;1(3):301-309.
25. Carrier S, Brock GB, Pommerville PJ, et al. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial. J Sex Med. 2005;2(5):685-698.
26. Axilrod AC. Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction. Curr Med Res Opin. 2007;23(12):3189-3198.
27. Rowland D, Perelman M, Althof S, et al. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med. 2004;1:225-232.
28. Shabsigh R, Rowland D. The Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision as an appropriate diagnostic for premature ejaculation. J Sex Med. 2007;4(5):1468-1478.
29. Waldinger MD. Premature ejaculation: state of the art. Urol Clin North Am. 2007;34(4):591-599, vii-viii.
30. Montague DK, Jarow J, Broderick G, et al; for the AUA Erectile Dysfunction Guideline Update Panel. AUA guideline on the pharmacologic management of premature ejaculation. J Urol. 2004;172(1):290-294
31. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (The) ICD-10. Tenth Revision. Vol 1. Geneva: World Health Organization; 1992:355-356.
32. McMahon CG, Abdo C, Incrocci L, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2004;1(1):58-65.
33. Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part I-Validity of DSM-IV-TR. J Sex Med. 2006;3:682-692.
34. Waldinger MD. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res. 2003;15(5):309-313.
35. Waldinger MD, Zwindermann AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res. 2004;16:369-381.
36. Waldinger MD. An empirical operationalization study of DSM IV diagnostic criteria for premature ejaculation. Int J Psychiatry Clin Pract. 1998;2:287-293.
37. Patrick DL, Althof SE, Pryor JL, et al. Premature ejaculation: an observational study of men and their partners. J Sex Med. 2005;2(3):358-367.
38. Symonds T, Perelman MA, Althof S, et al. Development and validation of a premature ejaculation diagnostic tool. Eur Urol. 2007;52(2):565-573.
39. Symonds T, Perelman M, Althof S, et al. Further evidence of the reliability and validity of the premature ejaculation diagnostic tool. Int J Impot Res. 2007;19(5):521-525.
40. Althof S, Rosen R, Symonds T, Mundayat R, May K, Abraham L. Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med. 2006;3(3):465-475.
41. Giuliano F, Patrick DL, Porst H, et al; for the 3004 study group. Premature ejaculation: results from a five-country European observational study. Eur Urol. 2007 EPub ahead of print.
42. Rowland DL. Psychophysiology of ejaculatory function and dysfunction. World J Urol. 2005;23(2):82-88.
43. Filippi S, Vignozzi L, Vannelli GB, Ledda F, Forti G, Maggi M. Role of oxytocin in the ejaculatory process. J Endocrinol Invest. 2003;26(suppl 3):82-86.
44. Bitran D, Hull EM. Pharmacological analysis of male rat sexual behavior. Neurosci Biobehav Rev. 1987;11(4):365-389.
45. Giuliano F, Clement P. Physiology of ejaculation: emphasis on serotonergic control. Eur Urol. 2005;48(3):408-417.
46. Corona G, Petrone L, Mannucci E, et al. Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. Eur Urol. 2004;46(5):615-622.
47. Carani C, Isidori AM, Granata A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005;90(12):6472-6479.
48. Gonen M, Kalkan M, Cenker A, Ozkardes H. Prevalence of premature ejaculation in Turkish men with chronic pelvic pain syndrome. J Androl. 2005;26(5):601-603.
49. Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA. Prevalence of chronic prostatitis in men with premature ejaculation. Urology. 2001;58(2):198-202.
50. Shamloul R. Chronic prostatitis in premature ejaculation: a cohort study in 153 men. J Sex Med. 2006;3(1):150-154.
51. Carson CC, Glasser DB, Laumann EO, West SL, Rosen RC. Prevalence and correlates of premature ejaculation among men aged 40 years and older: a United Stales nationwide population-based study. J Urol. 2003;169(suppl 4):321-322.
52. Symonds T, Roblin D, Hart K, Althof S. How does premature ejaculation impact a man's life? J Sex Marital Ther. 2003;29(5):361-370.
53. Semans J. Premature ejaculation: a new approach. S Med J. 1956;49:353-358.
54. Master VA, Turek PJ. Ejaculatory physiology and dysfunction. Urol Clin North Am. 2001;28(2):363-375.
55. McCabe MP. Evaluation of a cognitive behavior therapy program for people with sexual dysfunction. J Sex Marital Ther. 2001;27(3):259-271.
56. Hawton K, Catalan J. Prognostic factors in sex therapy. Behav Res Ther. 1986;24(4):377-385.
57. Cooper SE, Rowland DL. Treatment implications of behavioral and psychologic research on premature ejaculation. Curr Sex Health Rep. 2005;2:77-81.
58. Wyllie MG, Henry R, Morales A. Practical and effective treatment of premature ejaculation (PE) with a lidocaine-prilocaine spray. Proceedings of the American Urological Association, 98th Annual Meeting; 2003.
59. Busato W, Galindo CC. Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int. 2004;93(7):1018-1021.
60. Choi HK, Jung GW, Moon KH, et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology. 2000;55(2):257-261.
61. Choi HK, Xin ZC, Choi YD, Lee WH, Mah SY, Kim DK. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Int J Impot Res. 1999;11(5):261-264.
62. Stone KJ, Viera AJ, Parman CL. Off-label applications for SSRIs. Am Fam Physician. 2003;68:498-504.
63. McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int J Impot Res. 1999;11(5):241-245.
64. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol. 1998;18(4):274-281.
65. Montejo-González AL, Llorca G, Izquierdo JA, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997;23(3):176-194.
66. McMahon CG, McMahon CN, Leow LJ, Winestock CG. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. BJU Int. 2006;98(2):259-272.
67. Pryor JL, Althof SE, Steidle C, et al; for the Dapoxeline Study Group. Efficacy and tolerabilily of dapoxetine in the treatment of premature ejaculation: integrated analysis of two randomized, double-blind, placebo-controlled trials. Lancet. 2006;368(9539):929-937.
68. Safarinejad MR, Hosseini SY. Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol. 2006;26(1):27-31.
69. Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WJ, Cleves MA. Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med. 2008;5(1):188-193.
70. Grenier G, Byers ES. Rapid ejaculation: a review of conceptual, etiological, and treatment issues. Arch Sex Behav. 1995;24(4):447-472.
71. Risen CB. A guide to taking a sexual history. Clinical Sexuality. 1995;18(1):39-53.
72. Abdo CH. The male sexual quotient: a brief, self-administered questionnaire to assess male sexual satisfaction. J Sex Med. 2007;4(2):382-389.
73. Heruti R, Ashkenazi I, Shochat T, Tekes-Manova D, Justo D. Low scores in the sexual health inventory for men questionnaire may indicate sexual disorders other than erectile dysfunction. J Sex Med. 2005;2(2):181-186.
74. Seftel AD, Miner MM, Kloner RA, Althof SE. Office evaluation of male sexual dysfunction. Urol Clin North Am. 2007;34(4):463-482, v.
75. Perelman MA. A new combination treatment for premature ejaculation: a sex therapist's perspective. J Sex Med. 2006;3(6):1004-1012.